Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
mRNA Vaccines and Therapeutics Market Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030
... on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The ... Read More
-
Global Contract Research Organization (CRO) Growth Opportunities
... either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and emerging biopharma participants introducing novel therapies across various indications, primarily oncology, infectious ... Read More
-
HIV and HBV Therapies Market Report 2022-2032
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such as Rising Prevalence of ... Read More
-
Africa HIV Treatment Drugs Market 2023-2027
... during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Polycystic Kidney Disease - Drug Pipeline Landscape, 2022
... a form of chronic kidney disease which results in the reduction of kidney function, which may lead to kidney failure. PKD is mainly of two types: autosomal dominant PKD (ADPKD) and autosomal recessive PKD (ARPKD). ... Read More
-
Latin America Migraine Drugs Market 2023-2027
... 5.82% during the forecast period. Our report on the migraine drugs market in Latin America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Somatropin Market, by Dosage Form (Powder, Solvent), by Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Somatropin injection is used to replace growth hormone (a natural ... Read More
-
Digital Therapeutics: A New Age Medicine
... advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital ... Read More
-
Congenital Hyperinsulinism Treatment Market, by Disease Type (KATP-HI, GDH-HI, GK-HI, Other (SCHAD HI,HNF4A/HNF1A, etc.)), by Drug Type (Diazoxide, Octreotide, Glucagon, Nifedipine, Other (Sirolimus, Chlorothiazide, etc.), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Congenital hyperinsulinism(CHI) also called as hyperinsulinemic ... Read More
-
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027
... size was valued at US$6.8 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% during 2022-2027. The Global Atopic Dermatitis market report provides an executive-level overview of ... Read More
-
Global Plasmid DNA Manufacturing Market Size study & Forecast, by Grade (R&D Grade, GMP Grade), by Development (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), by Application (DNA Vaccines, Cell & Gene Therapy, Immunotherapy, Others), by Disease (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029
... (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029 Global Plasmid DNA Manufacturing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Pneumonia Therapeutics Market Size study & Forecast, by Therapeutics (Prevention Vaccines and Treatment Drugs), by Distribution Channel (Hospitals, Pharmaceutical Stores, and Others), and by Age Group (Pediatric, Adult, and Geriatric) and Regional Analysis, 2022-2029
... Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type ... Read More
-
Asthma - Drug Pipeline Landscape, 2022
... also due to excess mucus. It is characterised by airflow obstruction and triggers bronchospasms. Signs and symptoms of asthma includes shortness of breath, chest tightness, recurrent episodes of wheezing and cough. These symptoms vary from ... Read More
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Biopharma Production, Research, Diagnostics), End User (Biotech, CROs) - Global Forecast to 2027
... is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period. The market growth is primarily driven by factors such as increasing ... Read More
-
Bronchitis Treatments: Global Markets
... chronic. It also provides information regarding different drugs classes, including antibiotics, anti-inflammatories and bronchodilators. BCC Research analyzes and makes projections for each market and its segmentation, the regulatory environment, pipeline drugs and future aspects. The ... Read More
-
Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
... Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 15.5% during the forecast period. The growth of the market is projected to be driven by factors such as increasing number of ... Read More
-
Autoimmune Hepatitis - Pipeline Insights, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Neonatal respiratory distress syndrome - Pipeline Insight, 2022
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2032
... (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Myotonic Dystrophy: Disease Understanding Myotonic Dystrophy Overview According to the National Organization for Rare Disorders (NORD), myotonic dystrophy (DM) refers to a group of two ... Read More
-
Waldenstrom’s macroglobulinaemia - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Presbyopia - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Presbyopia Understanding ... Read More
-
Postherpetic Neuralgia - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Amyotrophic Lateral Sclerosis - Epidemiology Forecast - 2032
... (Germany, Spain, Italy, and France), the United Kingdom, Japan and China Geography Covered The United States EU-4 (Germany, France, Italy,and Spain), the United Kingdom Japan China Study Period: 2019-2032 Amyotrophic Lateral Sclerosis Disease Understanding and ... Read More
-
Genital Herpes - Epidemiology Forecast - 2032
... EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan China Study Period: 2019-2032 Genital Herpes understanding The ... Read More
-
Fanconi Anemia - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
Research Assistance
